Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000769436 | SCV000900829 | uncertain significance | Cardiomyopathy | 2016-01-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000769436 | SCV001350050 | likely benign | Cardiomyopathy | 2020-01-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001482034 | SCV001686394 | likely benign | Hypertrophic cardiomyopathy | 2024-08-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004985113 | SCV005453866 | likely benign | Cardiovascular phenotype | 2024-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |